Translational and HIF1α-dependent metabolic reprograming underpin oncometabolomeplasticity and synergy between oncogenic kinase inhibitors and biguanides.

Authors

Laura Hulea

Published

July 8, 2017

Add a comment...

Supporters

Support the authors with ResearchCoin

Preprint Server

Topics

DOI

10.1101/160879

License

cc-no

Translational and HIF1α-dependent metabolic reprograming underpin oncometabolomeplasticity and synergy between oncogenic kinase inhibitors and biguanides.

Authors

Laura Hulea

Published

July 8, 2017

Add a comment...

Supporters

Support the authors with ResearchCoin

Preprint Server

Topics

DOI

10.1101/160879

License

cc-no

Supporters

Support the authors with ResearchCoin

Preprint Server

Topics

DOI

10.1101/160879

License

cc-no

Paper

Paper

Paper

Paper

Translational and HIF1α-dependent metabolic reprograming underpin oncometabolomeplasticity and synergy between oncogenic kinase inhibitors and biguanides.

Supporters

Preprint Server

Topics

DOI

License

Translational and HIF1α-dependent metabolic reprograming underpin oncometabolomeplasticity and synergy between oncogenic kinase inhibitors and biguanides.

Supporters

Preprint Server

Topics

DOI

License

Supporters

Preprint Server

Topics

DOI

License